Cargando…
Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction
Autores principales: | Morales-Ponce, Francisco J., González-Pérez, Pablo, Blasco-Turrión, Sara, Sánchez-Brotons, Juan Antonio, Collado-Moreno, Carmen, Martínez-Romero, Pedro, Martínez-Morentín, Eduardo, Caro-Mateo, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105071/ https://www.ncbi.nlm.nih.gov/pubmed/33438179 http://dx.doi.org/10.5603/CJ.a2021.0002 |
Ejemplares similares
-
Intracoronary tenecteplase in STEMI with massive thrombus
por: Jayagopal, P.B., et al.
Publicado: (2018) -
Complications of intracoronary abciximab bolus-only versus standard protocol during percutaneous coronary intervention in acute coronary syndrome
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2014) -
The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary
por: Iversen, Allan, et al.
Publicado: (2008) -
Intracoronary versus Intravenous Administration of Abciximab in Patients with Acute Coronary Syndrome: A Meta-Analysis
por: Wang, Jie-Ning, et al.
Publicado: (2013) -
A Systematic Review of the Efficacy and Safety of Tenecteplase Versus Streptokinase in the Management of Myocardial Infarction in Developing Countries
por: Muoghalu, Chioma G, et al.
Publicado: (2023)